why choose us

First received: May 11, 2023

Clinical Trial: A Study of Enfortumab Vedotin in People With Urothelial Carcinoma of the Upper Urinary Tract

Study Status: Completed

Recruit Status: RECRUITING

Condition: Urothelial Carcinoma

Study Type: INTERVENTIONAL


Official Title: Neoadjuvant Enfortumab Vedotin in High-Grade Urothelial Carcinoma of the Upper Urinary Tract (Including Ureter and Renal Pelvis)

Brief Summary: The purpose of this study is to find out whether the study drug, enfortumab vedotin, is an effective and safe treatment for people who have urothelial carcinoma of the upper urinary tract.Study participants will be people who are not eligible to receive or have chosen not to receive the chemotherapy drug cisplatin for treatment of their cancer.In addition, all participants will be planning on having standard surgery to remove their tumor.

Read more